Safety, Pharmacodynamics and Pharmacokinetics of GSK2136525 Repeat Dose in Rheumatoid Arthritis

NCT01077531 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
12
Enrollment
INDUSTRY
Sponsor class

Stopped The risk-benefit ratio for patients has changed since we initiated the study, and that the study in its current form cannot be justified

Conditions

Interventions

Sponsor

GlaxoSmithKline